Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-50.62%
↑ 53% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-107.29%
Historical baseline
PeriodValue
2025-50.62%
2024-129.57%
2023-248.98%
20220.00%